These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 24907718)

  • 1. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
    Wang XZ; Jin ZK; Tian XH; Xue WJ; Tian PX; Ding XM; Zheng J; Li Y; Jing X; Luo ZZ
    Transpl Immunol; 2014 Jan; 30(1):18-23. PubMed ID: 24211610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcineurin inhibitors on paraoxonase and arylesterase activity after a kidney transplant.
    Kahvecioglu S; Ersoy A; Gullulu M; Dirican M
    Exp Clin Transplant; 2014 Aug; 12(4):334-42. PubMed ID: 24447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.
    Diémé B; Halimi JM; Emond P; Büchler M; Nadal-Desbarat L; Blasco H; Le Guellec C
    Transplantation; 2014 Jul; 98(2):195-201. PubMed ID: 24598938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients.
    Martínez-Flores JA; Serrano M; Morales P; Paz-Artal E; Morales JM; Serrano A
    J Immunol Methods; 2014 Jan; 403(1-2):62-5. PubMed ID: 24291342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients.
    Gathogo E; Harber M; Bhagani S; Levy J; Jones R; Hilton R; Davies G; Post FA;
    Transplantation; 2016 Apr; 100(4):871-8. PubMed ID: 26413990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation.
    De Paolis P; Favarò A; Piola A; Martini F; Cristiana G; Agrati C; Iappelli M; Di Giulio S
    Transplant Proc; 2011 May; 43(4):1013-6. PubMed ID: 21620039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of CD4 T-cell adenosine triphosphate levels monitoring in elderly renal transplant recipients.
    Wu Z; Zhou H; Yang S; Cai J; Wang Q; Liao L; Tan J
    Transplant Proc; 2012 Dec; 44(10):2986-91. PubMed ID: 23195011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
    Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK
    Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial.
    Ravaioli M; Neri F; Lazzarotto T; Bertuzzo VR; Di Gioia P; Stacchini G; Morelli MC; Ercolani G; Cescon M; Chiereghin A; Del Gaudio M; Cucchetti A; Pinna AD
    Transplantation; 2015 Aug; 99(8):1625-32. PubMed ID: 25757214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
    Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
    Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus.
    Fuchs U; Zittermann A; Ensminger SM; Schulz U; Gummert JF
    Transpl Immunol; 2014 Aug; 31(2):87-91. PubMed ID: 24932812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.
    Schulz-Juergensen S; Burdelski MM; Oellerich M; Brandhorst G
    Ther Drug Monit; 2012 Feb; 34(1):4-10. PubMed ID: 22210096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes.
    Kobashigawa JA; Kiyosaki KK; Patel JK; Kittleson MM; Kubak BM; Davis SN; Kawano MA; Ardehali AA
    J Heart Lung Transplant; 2010 May; 29(5):504-8. PubMed ID: 20133166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipients.
    Vittoraki AG; Boletis JN; Darema MN; Kostakis AJ; Iniotaki AG
    Transplant Proc; 2014; 46(1):108-14. PubMed ID: 24507034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.